NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘Advent Venture Partners’

7 February 2014

Gene therapy company uniQure raises over $80m via IPO

biotech_lrg Venture capital-backed gene therapy specialist uniQure has raised nearly $82m via an IPO on the Nasdaq exchange, which was priced above the indicative range.

3 January 2014

Gene therapy company uniQure plans $75m Nasdaq IPO

stocks2_lrg Venture capital-backed gene therapy specialist uniQure plans to raise $75m via an IPO on the Nasdaq exchange, according to a filing with US securities regulators.

8 October 2013

Sofinnova Ventures leads $20m Series D for biotech company Versartis

biotech_lrg Sofinnova Ventures has led a $20m Series D round for Versartis to help the biotech company prepare for an international Phase 3 pediatric trial of VRS-317, a treatmet for patients with growth hormone deficiency.

4 April 2013

Venture backers exit Ubiquisys through $310m Cisco purchase

telecoms5sq_lrg Venture capital-backed phone network technology company Ubiquisys has been bought by Cisco in a $310m deal.

17 December 2012

Ian Nicholson joins Advent Venture Partners life sciences team

Ian Nicholson Advent Venture Partners - AltAssets Private Equity News London-based Advent Venture Partners has hired Ian Nicholson as an operating partner for its life sciences division.

15 August 2012

UK 3G tech developer Ubiquisys raises $19m

UK 3G technology company Ubiquisys has raised $19m in an oversubscribed round from China's Mobile Internet Capital and Nissay Capital, together with existing investors including 5CCG/Sallfort Privatbank, Accel Partners, Advent Venture Partners, Atlas Venture and Yasuda.


Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2014